N@N

Market Maker Surveillance Report. FXEN, EMIS, URBN, RGEN, GYSLF, GTHP, Losing Stocks With Lowest Price Friction For Monday, Ma

March 7, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 2381 companies with "abnormal" market making, 1404 companies with positive Friction Factors and 3970 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. FX ENERGY INC (NASDAQ:FXEN), EMISPHERE TECHNOLOGIES INC (NASDAQ:EMIS), URBAN OUTFITTERS INC (NASDAQ:URBN), REPLIGEN CORP (NASDAQ:RGEN), GREYSTAR RESOURCES LTD (OTC:GYSLF), GUIDED THERAPEUTICS INC (OTC:GTHP). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     FXEN       $-1.370      -12.18%      617,800         41.12%       871,924         58.03%       -254,124        -1,855  
     EMIS       $-0.170      -10.97%      40,305          27.16%       108,096         72.84%       -67,791         -3,988  
     URBN       $-4.420      -11.48%      2,447,974       43.55%       2,910,840       51.78%       -462,866        -1,047  
     RGEN       $-1.360      -27.70%      693,833         48.57%       726,834         50.88%       -33,001         -243    
     GYSLF      $-0.397      -11.93%      31,711          22.73%       65,641          47.06%       -33,930         -855    
     GTHP       $-0.330      -24.81%      340,309         36.56%       578,437         62.15%       -238,128        -7,216  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows FXEN with a dollar loss Monday of $-1.37000 and a Friction Factor of -1,855 shares. That means that it only took 1,855 more shares of selling than buying to move FXEN lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

FX ENERGY INC (NASDAQ:FXEN) - FX Energy, Inc., together with its subsidiaries, operates as an independent oil and gas exploration and production company with principal operations in Poland. It primarily explores on the Rotliegend sandstones of the Permian Basin, Poland. The company holds interests in 9 project areas encompassing approximately 4.7 million gross acres in Poland. It also explores for and produces oil from fields in Montana and Nevada, the United States; and holds interests in an oilfield services company that offers contract drilling and well-servicing operations in northern Montana. In addition, the company has projects involving the exploration and exploitation of oil and gas prospects in partnership with the Polish Oil and Gas Company. As of December 31, 2009, its total proved estimated oil and gas reserves were 50.4 billion cubic feet of natural gas equivalent. The company was founded in 1989 and is headquartered in Salt Lake City, Utah.

EMISPHERE TECHNOLOGIES INC (NASDAQ:EMIS) - Emisphere Technologies, Inc., a biopharmaceutical company, focuses on the delivery of therapeutic molecules and pharmaceutical compounds using its eligen technology. The eligen technology could be applied to the oral route of administration, as well as the other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal, or transdermal. The companys product pipeline includes Oral Salmon Calcitonin, which is in Phase III clinical trials for the treatment of osteoporosis and osteoarthritis; Oral Recombinant Parathyroid Hormone, which is in Phase I clinical trials for the treatment of osteoporosis; and Oral Heparin that is in Phase III clinical trials, as well as Oral Low Molecular Weight Heparin, which is in Phase I clinical trials for the treatment of cardiovascular diseases. Its products under development also comprise Oral Insulin, which is in Phase II clinical trials, as well as Oral Glucagon-Like Peptides, which is in Phase I clinical trials for the treatment of diabetes; Oral Recombinant Human Growth Hormone that is in Phase I clinical trials for the treatment of growth disorders; and Oral Acyclovir, an anti-viral compound that is in Phase I clinical trials. In addition, the companys product pipeline consists of Oral PYY 3-36, which is in Phase I clinical trials for treating obesity; Oral Cromolyn Sodium that is in Phase I clinical trials for the treatment of asthma/allergies; and Oral Gallium, a preclinical stage product candidate, for oncology treatment. Emisphere Technologies has collaboration agreements with Novartis Pharma AG; Roche; and Genta, Inc. The company was founded in 1985. It was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. The company is headquartered in Cedar Knolls, New Jersey.

URBAN OUTFITTERS INC (NASDAQ:URBN) - Urban Outfitters, Inc. operates lifestyle specialty retail stores under the Urban Outfitters, Anthropologie, Free People, and Terrain brands; and engages in the apparel wholesale business under the Free People and Leifsdottir brands. Its Urban Outfitters stores offer womens and mens fashion apparel, footwear, and accessories, as well as gifts and apartment wares, such as rugs, pillows, shower curtains, books, candles, and novelties to young adults; and Anthropologie stores offer womens casual apparel and accessories, gifts, and decorative items, as well as home furnishings, including furniture, rugs, lightings and antiques, table top items, and beddings for women. The companys Free People retail stores primarily offer Free People branded merchandise, such as casual womens apparel, accessories, and gifts; and Terrain retail stores provide lifestyle home and garden products combined with antiques, live plants, flowers, wellness products, and accessories, as well as various landscape and design service solutions for men and women. Urban Outfitters, Inc. offers its products directly to consumers through its e-commerce Web sites, urbanoutfitters.com, anthropologie.com, freepeople.com, urbanoutfitters.co.uk, and shopterrain.com, as well as through its Urban Outfitters, Anthropologie, and Free People catalogs. As of January 31, 2010, it operated 155 Urban Outfitters stores, 137 Anthropologie stores, 34 Free People stores, and 1 Terrain garden center in the United States, Canada, and Europe. The company was founded in 1970 and is based in Philadelphia, Pennsylvania.

REPLIGEN CORP (NASDAQ:RGEN) - Repligen Corporation develops novel therapeutics primarily for the treatment of diseases of the central nervous system. The company offers Protein A products, which are used in the production and purification of therapeutic monoclonal antibodies. Repligen also licenses its patent covering the use of CTLA4-Ig, a regulator of the activity of the immune system, and receives royalties from Bristol-Myers Squibb based on their U.S. Sales of Orencia. The companys development stage products include RG1068, human secretin for improved MRI of the pancreas; RG2417, uridine for bipolar depression; HDAC inhibitors for Friedreichs ataxia; and RG-SMA for spinal muscular atrophy. The company sells its Protein A products primarily through value-added resellers, as well as through distributors internationally. Repligen Corporation was founded in 1981 and is headquartered in Waltham, Massachusetts.

GREYSTAR RESOURCES LTD (OTC:GYSLF) - Greystar Resources Ltd. engages in the acquisition, exploration, and development of mineral resource properties. The company primarily holds interests in the Angostura gold-silver project located in the northeastern region of Colombia. It operates in Canada and Colombia. The company is headquartered in Vancouver, Canada.

GUIDED THERAPEUTICS INC (OTC:GTHP) - Guided Therapeutics, Inc., a medical technology company, together with its subsidiaries, develops and offers products for the non-invasive cervical cancer detection and diabetes markets. The company is developing a non-invasive cervical cancer detection product using its biophotonic technologies, which could be used to identify cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix to produce a map or image of diseased tissue. Guided Therapeutics has an agreement with Konica Minolta Opto Inc. for the development of LightTouch prototype devices for the esophageal cancer detection application, as well as license agreements with Georgia Tech Research Corporation. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics was founded in 1992 and is based in Norcross, Georgia.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net